Quest Diagnostics Incorporated DGX Stock
Quest Diagnostics Incorporated Price Chart
Quest Diagnostics Incorporated DGX Financial and Trading Overview
| Quest Diagnostics Incorporated stock price | 171.23 USD |
| Previous Close | 156.23 USD |
| Open | 155.92 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 800 |
| Day's Range | 155.49 - 157.34 USD |
| 52 Week Range | 119.59 - 157.34 USD |
| Volume | 883.73K USD |
| Avg. Volume | 839.75K USD |
| Market Cap | 17.47B USD |
| Beta (5Y Monthly) | 0.889 |
| PE Ratio (TTM) | 21.183537 |
| EPS (TTM) | 7.9 USD |
| Forward Dividend & Yield | 3 (1.90%) |
| Ex-Dividend Date | October 4, 2024 |
| 1y Target Est | 154.98 USD |
DGX Valuation Measures
| Enterprise Value | 22.41B USD |
| Trailing P/E | 21.183537 |
| Forward P/E | 16.300104 |
| PEG Ratio (5 yr expected) | 2.7 |
| Price/Sales (ttm) | 1.8696158 |
| Price/Book (mrq) | 2.6331506 |
| Enterprise Value/Revenue | 2.398 |
| Enterprise Value/EBITDA | 12.512 |
Trading Information
Quest Diagnostics Incorporated Stock Price History
| Beta (5Y Monthly) | 0.889 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 157.34 USD |
| 52 Week Low | 119.59 USD |
| 50-Day Moving Average | 145.99 USD |
| 200-Day Moving Average | 136.84 USD |
DGX Share Statistics
| Avg. Volume (3 month) | 839.75K USD |
| Avg. Daily Volume (10-Days) | 576.77K USD |
| Shares Outstanding | 111.32M |
| Float | 110.4M |
| Short Ratio | 2.72 |
| % Held by Insiders | 0.43% |
| % Held by Institutions | 91.69% |
| Shares Short | 2.79M |
| Short % of Float | 2.85% |
| Short % of Shares Outstanding | 2.51% |
Dividends & Splits
| Trailing Annual Dividend Rate | 2.92 |
| Trailing Annual Dividend Yield | 1.86% |
| 5 Year Average Dividend Yield | 191.00% |
| Payout Ratio | 0.38869998 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2023 |
| Most Recent Quarter (mrq) | June 30, 2024 |
| Next Fiscal Year End | December 31, 2024 |
Profitability
| Profit Margin | 8.98% |
| Operating Margin (ttm) | 15.51% |
| Gross Margin | 33.00% |
| EBITDA Margin | 19.16% |
Management Effectiveness
| Return on Assets (ttm) | 6.12% |
| Return on Equity (ttm) | 13.58% |
Income Statement
| Revenue (ttm) | 9.35B USD |
| Revenue Per Share (ttm) | 83.82 USD |
| Quarterly Revenue Growth (yoy) | 2.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | 1.79B USD |
| Net Income Avi to Common (ttm) | 836M USD |
| Diluted EPS (ttm) | 7.41 |
| Quarterly Earnings Growth (yoy) | -2.60% |
Balance Sheet
| Total Cash (mrq) | 271M USD |
| Total Cash Per Share (mrq) | 2.43 USD |
| Total Debt (mrq) | 5.09B USD |
| Total Debt/Equity (mrq) | 75.55 USD |
| Current Ratio (mrq) | 1.002 |
| Book Value Per Share (mrq) | 59.613 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.25B USD |
| Levered Free Cash Flow (ttm) | 787.88M USD |
Profile of Quest Diagnostics Incorporated
| Country | United States |
| State | NJ |
| City | Secaucus |
| Address | 500 Plaza Drive |
| ZIP | 07094 |
| Phone | 973 520 2700 |
| Website | https://www.questdiagnostics.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 50000 |
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Q&A For Quest Diagnostics Incorporated Stock
What is a current DGX stock price?
Quest Diagnostics Incorporated DGX stock price today per share is 171.23 USD.
How to purchase Quest Diagnostics Incorporated stock?
You can buy DGX shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Quest Diagnostics Incorporated?
The stock symbol or ticker of Quest Diagnostics Incorporated is DGX.
Which industry does the Quest Diagnostics Incorporated company belong to?
The Quest Diagnostics Incorporated industry is Diagnostics & Research.
How many shares does Quest Diagnostics Incorporated have in circulation?
The max supply of Quest Diagnostics Incorporated shares is 111.63M.
What is Quest Diagnostics Incorporated Price to Earnings Ratio (PE Ratio)?
Quest Diagnostics Incorporated PE Ratio is 21.67468300 now.
What was Quest Diagnostics Incorporated earnings per share over the trailing 12 months (TTM)?
Quest Diagnostics Incorporated EPS is 7.9 USD over the trailing 12 months.
Which sector does the Quest Diagnostics Incorporated company belong to?
The Quest Diagnostics Incorporated sector is Healthcare.
Quest Diagnostics Incorporated DGX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| S&P 500 INDEX SPX | 5802.82 USD — |
-0.67
|
2.56B USD — | 5767.41 USD — | 5829.51 USD — | — - | 2.56B USD — |
| S&P 500 (Yahoo.com) GSPC | 5802.82 USD — |
-0.67
|
2.55B USD — | 5767.41 USD — | 5829.51 USD — | — - | 2.55B USD — |
| NASDAQ US BuyBack Achievers Sel DRBS | 2340.09 USD — |
+0.42
|
— — | 2336.31 USD — | 2349.71 USD — | — - | — — |
| NASDAQ US Broad Dividend Achiev DAA | 3711.02 USD — |
-0.3
|
— — | 3692.06 USD — | 3722.28 USD — | — - | — — |
| NYSE Composite Index NYA | 19534.84 USD — |
-0.15
|
— — | 19390.86 USD — | 19587.79 USD — | — - | — — |
| NASDAQ Global BuyBack Achievers DRBG | 2363.7 USD — |
-0.47
|
— — | 2348.58 USD — | 2382.23 USD — | — - | — — |
| NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
- {{ link.label }} {{link}}